𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytomegalovirus infections in organ transplantation and post transfusion

✍ Scribed by David J. Lang

Publisher
Springer Vienna
Year
1972
Tongue
English
Weight
962 KB
Volume
37
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transfusion-acquired cytomegalovirus inf
Transfusion-acquired cytomegalovirus infection in cardiac surgery patients
✍ Dr. J. K. Preiksaitis; F. C. Grumet; W. K. Smith; T. C. Merigan 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

## Abstract The incidence of transfusion‐acquired primary cytomegalovirus (CMV) infection was studied in 483 cardiac surgery patients. Ninety‐six patients (20%) were found to lack antibody to CMV [CMV Ab(−)] as measured by radioimmunoassay. Sixty‐eight CMV Ab(−) were followed by viral culture and/o

Unusual manifestations of primary cytome
Unusual manifestations of primary cytomegalovirus infection in patients without HIV infection and without organ transplants
✍ Brendan Crowley; Jed Dempsey; Ade Olujohungbe; Abdul Khan; Ken Mutton; C.A. Hart 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Primary cytomegalovirus (CMV) infection with marked constitutional symptoms is rare in immunocompetent individuals and in those with iatrogenic immunosuppression, except transplant recipients. Four patients admitted to hospital with clinical illnesses associated with primary CMV infection were ident

The case for cytomegalovirus prophylaxis
The case for cytomegalovirus prophylaxis in solid organ transplantation
✍ David R. Snydman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract Cytomegalovirus prevention strategies have been debated for the past decade. This review argues in favour of the prophylaxis strategy. Clinical trials comparing prophylaxis to pre‐emptive therapy have, thus far, had insufficient power to differentiate strategies, especially with regard

Transfusion-acquired cytomegalovirus inf
Transfusion-acquired cytomegalovirus infection in children in a hyperendemic area
✍ Ping-Ing Lee; Mei-Hwei Chang; Wuh-Liang Hwu; Chuan-Liang Kao; Chin-Yun Lee 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

## Abstract Thirty‐nine children without previous cytomegalovirus (CMV) infection received blood transfusion in the National Taiwan University Hospital. The overall transfusion‐acquired CMV infection rate was 36% (14/39). Donor CMV seropositive rate was 70%. None of the nine children who had receiv

Question of using valganciclovir for cyt
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients
✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n ϭ 49) compared with the standard dose of ganciclovir (n ϭ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au